Regulus Therapeutics Inc. (44)
Browse by Contract Category
Contracts
-
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2023
(Filed With SEC on March 23, 2023)
-
Description of Common Stock
(Filed With SEC on March 23, 2023)
-
Assignment and Assumption of Lease, dated February 11, 2021, by and between the Registrant and Turning Point Therapeutics, Inc
(Filed With SEC on March 9, 2021)
-
Employment Agreement between the Registrant and Denis Drygin
(Filed With SEC on March 9, 2021)
-
Second Amendment to Second Amended and Restated Collaboration and License Agreement, dated August 25, 2020, by and between the Registrant and Sanofi
(Filed With SEC on November 5, 2020)
-
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2023
(Filed With SEC on March 23, 2023)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2023
(Filed With SEC on March 23, 2023)
-
Regulus Therapeutics Inc. 2022 Employee Stock Purchase Plan
(Filed With SEC on August 11, 2022)
-
Form of Common Stock Certificate of the Registrant
(Filed With SEC on August 11, 2022)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Description of Common Stock
(Filed With SEC on March 11, 2022)
-
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and among the Registrant and Oxford Finance, LLC
(Filed With SEC on March 11, 2022)
-
Eleventh Amendment to Loan and Security Agreement, dated December 31, 2021, by and between the Company and Oxford Finance LLC
(Filed With SEC on January 5, 2022)
-
Lease Agreement, dated February 11, 2021, by and between the Registrant and ARE-SD Region No. 44 LLC
(Filed With SEC on March 9, 2021)
-
Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on March 9, 2021)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020
(Filed With SEC on March 9, 2021)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019
(Filed With SEC on March 9, 2021)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on December 4, 2020)
-
Securities Purchase Agreement, dated December 1, 2020, by and among the Company and the Purchasers
(Filed With SEC on December 4, 2020)
-
Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and between the Registrant and Oxford Finance, LLC
(Filed With SEC on November 5, 2020)
-
Ninth Amendment to Loan and Security Agreement, dated May 1, 2020, by and between the Registrant and Oxford Finance, LLC
(Filed With SEC on May 14, 2020)
-
Description of Common Stock
(Filed With SEC on March 12, 2020)
-
Employment Agreement, dated August 30, 2019, by and between the Registrant and Cris Calsada
(Filed With SEC on November 12, 2019)
-
Non-Employee Director Compensation Policy, as amended
(Filed With SEC on November 12, 2019)
-
Lease Agreement, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC
(Filed With SEC on August 8, 2019)
-
Regulus Therapeutics Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Registrants Current Report on Form 8-K (File No. 001-35670, filed with the...
(Filed With SEC on August 8, 2019)
-
First Amendment to Lease, dated June 19, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC
(Filed With SEC on August 8, 2019)
-
Consulting agreement, dated July 26, 2019, by and between the Registrant and Daniel R. Chevallard
(Filed With SEC on August 8, 2019)
-
Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada
(Filed With SEC on July 30, 2019)
-
Seventh Amendment to Loan and Security Agreement, dated April 9, 2019, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on May 10, 2019)
-
Employment Agreement between the Registrant and Christopher Aker, dated July 24, 2018
(Filed With SEC on May 10, 2019)
-
Eighth Amendment to Loan and Security Agreement, dated May 3, 2019, by and between the Company and Oxford Finance LLC
(Filed With SEC on May 9, 2019)
-
Securities Purchase Agreement, dated May 3, 2019, by and among the Company and the Purchasers
(Filed With SEC on May 9, 2019)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on May 9, 2019)
-
Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc
(Filed With SEC on March 18, 2019)
-
Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC
(Filed With SEC on March 18, 2019)
-
First Amendment to Second Amended and Restated Collaboration and License Agreement, dated November 5, 2018, by and between the Registrant and Sanofi
(Filed With SEC on March 18, 2019)
-
Second Amendment to Lease Agreement, dated February 25, 2019, by and between the Registrant and ARE-SD Region No. 44 LLC
(Filed With SEC on March 18, 2019)
-
Sixth Amendment to Loan and Security Agreement, dated March 7, 2019, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on March 18, 2019)
-
Fourth Amendment to Loan and Security Agreement, dated November 5, 2018, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on March 18, 2019)
-
Fifth Amendment to Loan and Security Agreement, dated January 31, 2019, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on February 1, 2019)